Nuclear medicine and paediatrics: Radiopharmaceutical point of view

被引：1
|
作者：
Rouy, J-C. [1 ]
Tafani, M. [2 ]
Guillet, J. [1 ]
机构：
[1] Ctr Hosp Agen, Serv Biophys & Med Nucl, F-47923 Agen 9, France
[2] CHU Toulouse, Hop Purpan, F-31059 Toulouse 9, France
来源：
MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE | 2012年 / 36卷 / 03期
关键词：
Radiopharmaceutical; Pediatrics; Pharmacokinetics; Exploration; Physiology;
D O I：
10.1016/j.mednuc.2012.01.006
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
Nuclear medicine applied to pediatrics widely benefited from evolutions brought to radiopharmaceutical drugs. The use of less irradiant radionuclides in the state of track contributed to the development of the nuclear pediatrics, while optimizing the administered doses. For this purpose, diverse methods of calculation were proposed, the most recent by the European Association of Nuclear Medicine (EANM) using a classification according to radiopharmaceutical drugs. The prescription of these drugs for children concerns the various organs such as kidneys, bone, cerebral tissues, thyroid gland, and cancerous tissues. But it has to take into account the pharmacokinetics of drugs in view of the physiological peculiarities of the child, as the immaturity of the kidney, the maturation and the bone growth, the activation of the brown fatty tissue, the cerebral distribution of drugs. (c) 2012 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码：124 / 127
页数：4
相关论文
共 50 条
  • [1] Nuclear medicine in paediatrics.
    Piepsz, A
    [J]. MEDECINE NUCLEAIRE, 1996, 20 (7-8): : 518 - 521
  • [2] Thyroid Sonography: Nuclear Medicine Point of View
    Staudenherz, Anton
    Leitha, Thomas
    [J]. CURRENT RADIOLOGY REPORTS, 2019, 7 (04)
  • [3] Thyroid Sonography: Nuclear Medicine Point of View
    Anton Staudenherz
    Thomas Leitha
    [J]. Current Radiology Reports, 7
  • [4] "Nuclear" medicine physicians as communicators: Their point of view on the aftermath of "nuclear" disaster
    Staudenherz A.
    Sinzinger H.
    [J]. Wiener Medizinische Wochenschrift, 2012, 162 (3-4) : 60 - 66
  • [5] Radiopharmaceutical prescription in nuclear medicine departments
    Biechlin-Chassel, M. -L.
    Lao, S.
    Bolot, C.
    Francois-Joubert, A.
    [J]. MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2010, 34 (11): : 608 - 611
  • [6] Imaging vascular prosthesis infections: The nuclear medicine point of view
    Liberatore, M
    [J]. NUCLEAR MEDICINE IN THE MANAGEMENT OF INFLAMMATORY AND INFECTIOUS DISEASES, 2003, : 123 - 127
  • [7] Fever of unknown origin and endocarditis: The nuclear medicine point of view
    Buscombe, J
    [J]. NUCLEAR MEDICINE IN THE MANAGEMENT OF INFLAMMATORY AND INFECTIOUS DISEASES, 2003, : 91 - 97
  • [8] Hand exposure in nuclear medicine technologists working in the radiopharmaceutical laboratory in diagnostic nuclear medicine
    Sobral, C.
    Prior, J. O.
    Perez, E.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S226 - S226
  • [9] Computerization and security of the radiopharmaceutical drug circuit in nuclear medicine
    Masson, L.
    Deshayes, S.
    Bresson, A.
    Larbre, H.
    Rey, J. -B.
    Liehn, J. -C.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2013, 35 (05) : 967 - 967
  • [10] Radiochemical Investigations for Radiopharmaceutical Nuclear Medicine at JINR Laboratory of Nuclear Problems
    Filosofov, D. V.
    Baimukhanova, A. E.
    Kurakina, E. S.
    Karaivanov, D. V.
    Velichkov, A. I.
    Radchenko, V. I.
    Yakushev, E. A.
    [J]. PHYSICS OF PARTICLES AND NUCLEI, 2023, 54 (02) : 321 - 363
12345